Founded in 1991, BlueCross Biopharmaceutical (Beijing) Co., Ltd., one of the top ten brands of pregnancy test sticks/early pregnancy test strips, proposed and introduced the concept and method of "in vitro rapid testing" earlier, and is a foreign-invested high-tech enterprise integrating development, production, sales and service
Blue Cross Biopharmaceutical (Beijing) Co., Ltd. is a foreign-invested high-tech enterprise integrating development, production, sales and service. As early as 1990, Blue Cross took the lead in proposing and introducing the concept and method of "in vitro rapid detection" in China, and established the first generation and the second generation of rapid detection products in China between 1991 and 1995, and launched the first product of standardized commercial mass production, namely early pregnancy detection reagents, the first to obtain the invention and utility model patent of China's first rapid detection method and device, and jointly drafted and formulated China's first rapid detection product with the National Biological Products Standards Committee. In 1997, as the only production-oriented enterprise in China, it participated in the world's largest pharmaceutical and medical device fair MEDICA, and realized the export of technical products, and in the past 20 years, Blue Cross has passed the international and domestic authoritative certification of European CE, ISO13485, ISO9001, China SFDAGMP, in vitro diagnostic reagent production implementation rules, etc. The production of products is strictly in accordance with the international quality management system, and has always maintained a leading banner in the market competition pattern of the domestic industry's reputation brand, market share, product quality and price stability.
The mission of Blue Cross is to devote itself to the development and production of colloidal gold method series of rapid detection reagents. The company's products are significantly different from similar manufacturers' products in terms of raw material selection, product production process and quality control. Since 2000, Blue Cross has built a 4A-level intelligent office building, a production and purification workshop from 100,000 to 100 levels, logistics warehousing and ancillary facilities, with a construction area of 15,000 square meters.
In recent years, the company has rapidly expanded its product field, successfully developed and produced more than 20 products in six series, nearly 100 kinds of products, and obtained 4 China SFDA new drug certificates and 11 medical device certificates, becoming one of the largest and most influential industrialization bases for rapid in vitro detection reagent products in China.
Blue Cross has established a huge marketing network in China, the company has agents in 30 provinces and municipalities, 2,000 regions and 30,000 townships, and has nearly 3,000 direct customers such as hospitals, clinics, blood stations, epidemic prevention stations, physical examination centers, customs and so on. The company's products are exported, and over the years, it has established harmonious and stable cooperative relations with more than 100 customers in more than 70 countries.
Innovation, excellent quality and honest service are always the constant tenets of Blue Cross.
